THE ROLE OF PYRAZINAMIDE IN TUBERCULOSIS CHEMOTHERAPY

被引：85

作者：

STEELE, MA ^{[1
]}

DESPREZ, RM ^{[1
]}

机构：

[1] VANDERBILT UNIV, MED CTR, SCH MED, NASHVILLE, TN 37232 USA

来源：

关键词：

D O I：

10.1378/chest.94.4.845

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：845 / 850

页数：6

共 70 条

[1] TUBERCULOSIS IN PATIENTS WITH END-STAGE RENAL-DISEASE
ANDREW, OT
SCHOENFELD, PY
HOPEWELL, PC
HUMPHREYS, MH
[J]. AMERICAN JOURNAL OF MEDICINE, 1980, 68 (01) : 59 - 65
[2] ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330
[3] [Anonymous], 1983, TUBERCLE, V64, P73
[4] [Anonymous], 1978, Lancet, V2, P334
[5] [Anonymous], 1987, Am Rev Respir Dis, V136, P1339
[6] BAREGGI SR, 1987, ARZNEIMITTEL-FORSCH, V37-2, P849
[7] BOBROWITZ ID, 1980, LUNG, V157, P117
[8] SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO PYRAZINAMIDE AND ITS RELATIONSHIP TO PYRAZINAMIDASE ACTIVITY
BUTLER, WR
KILBURN, JO
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) : 600 - 601
[9] CAMPAGNA M, 1954, AM REV TUBERC PULM, V69, P334
[10] CLINI V, 1970, ANTIBIOT CHEMOTHER, V16, P20